Trade Summary

5 days ago, Megna Michael R, serving as CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International, Plc (KNSA), sold 6,625 shares at $46.69 per share, for a total transaction value of $309,321.00. Following this transaction, Megna Michael R now holds 27,418 shares of KNSA.

This sale represents a 19.00% decrease in Megna Michael R's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 9, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 13, 2026, 4 days after the trade was made.

Kiniksa Pharmaceuticals International, Plc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.